Mar. 15, 2011 (Marketwire Canada) --
TORONTO, ONTARIO --
Attention: Business/Financial Editors
The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, announced that on March 14, 2011, in accordance with its stock option plan, the board of directors of Medipattern approved the grant of an aggregate of 100,000 incentive stock options to a director and officer of the Company. The options are exercisable on or before March 14, 2016 at an exercise price of $0.40 per share.
About The Medipattern Corporation:
Medipattern® is a pioneer in the development of imaging software solutions that help medical practitioners better understand lesions and critical anatomy. Medipattern uses its Cadenza™ Algorithm Technology to power Visualize:Vascular™ 3D reconstruction of areas of interest within the vessel as well as our first-to-market, award-winning B-CAD® advanced breast ultrasound computer aided detection (CAD). For more information, please visit the Company's website at: www.medipattern.com.
B-CAD® and Medipattern® are registered marks of The Medipattern Corporation. Visualize:Vascular™ and Cadenza™ are trademarks of The Medipattern Corporation.
Forward-looking statements
This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential", and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The Medipattern Corporation
CEO
(416) 744-0009 ext. 224
jcollins@medipattern.com
Spinnaker Capital Markets Inc.
(416) 962-3300 ext. 226
ko@spinnakercmi.com